Is there a bedside tool that provides an indicator of Nasal High Flow outcomes?
The validated ROX index provides an indicator of outcomes in adults with AHRF receiving Nasal High Flow therapy.
4 time intervals are observed: 2, 6, 12 and >12 hours. It's an easy-to-use dynamic bedside tool.
- Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernandez G, et al. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High Flow Therapy. Am J Respir Crit Care Med. 2018 Dec 21. [Epub ahead of print]